KA/EN
Register
Medicines reference
Search
Search
Product

Arbimectin

Favourites

Ivermectin + Umifenovir hydrochloride · Agrobioprom JSC

4 forms: tablet. In force in Georgia: 4 of 4 (veterinary register).

Forms and doses4 of 4 in force in Georgia

The dose from the product's label, by species and weight. Check the label of the pack you use.

Choose species and weight; the matching row will be highlighted.
Form Species Weight Dose Frequency Georgia
0.75/10 mg tablets, Tablet · Cat 1–2 kg Cat 1–2 kg 1/4 tablet
Give individually with a small amount of food or directly, whole, crushed or dissolved in water. Keep fresh drinking water available. Do not use in pregnancy or lactation, under 10 weeks, below 1 kg, or with ingredient hypersensitivity. Collies, Shelties and Bobtails require veterinary supervision. Use cautiously with hypertension or epilepsy. Do not combine with other macrocyclic-lactone medicines. The longer twice-daily 10-14-day schedule applies only to feline leukaemia, immunodeficiency or coronavirus-enteritis viral-load reduction under veterinary care.
 · treatment: twice daily for 5-7 days, then once daily for 5 days; prevention: once daily for 3-4 days		 treatment: twice daily for 5-7 days, then once daily for 5 days; prevention: once daily for 3-4 days Georgia Yes, veterinary
In force until 26 Jul 2029
Veterinary (National Food Agency)
In the register: არბიმექტინი
№ 000712
Verified on: 21 Oct 2026
0.75/10 mg tablets, Tablet · Cat 2–2.5 kg Cat 2–2.5 kg 1/2 tablet
Give individually with a small amount of food or directly, whole, crushed or dissolved in water. Keep fresh drinking water available. Do not use in pregnancy or lactation, under 10 weeks, below 1 kg, or with ingredient hypersensitivity. Collies, Shelties and Bobtails require veterinary supervision. Use cautiously with hypertension or epilepsy. Do not combine with other macrocyclic-lactone medicines. The longer twice-daily 10-14-day schedule applies only to feline leukaemia, immunodeficiency or coronavirus-enteritis viral-load reduction under veterinary care.
 · treatment: twice daily for 5-7 days, then once daily for 5 days; prevention: once daily for 3-4 days		 treatment: twice daily for 5-7 days, then once daily for 5 days; prevention: once daily for 3-4 days Georgia Yes, veterinary
In force until 26 Jul 2029
Veterinary (National Food Agency)
In the register: არბიმექტინი
№ 000712
Verified on: 21 Oct 2026
0.75/10 mg tablets, Tablet · Cat 2.5–5 kg Cat 2.5–5 kg 1 tablet
Give individually with a small amount of food or directly, whole, crushed or dissolved in water. Keep fresh drinking water available. Do not use in pregnancy or lactation, under 10 weeks, below 1 kg, or with ingredient hypersensitivity. Collies, Shelties and Bobtails require veterinary supervision. Use cautiously with hypertension or epilepsy. Do not combine with other macrocyclic-lactone medicines. The longer twice-daily 10-14-day schedule applies only to feline leukaemia, immunodeficiency or coronavirus-enteritis viral-load reduction under veterinary care.
 · treatment: twice daily for 5-7 days, then once daily for 5 days; prevention: once daily for 3-4 days		 treatment: twice daily for 5-7 days, then once daily for 5 days; prevention: once daily for 3-4 days Georgia Yes, veterinary
In force until 26 Jul 2029
Veterinary (National Food Agency)
In the register: არბიმექტინი
№ 000712
Verified on: 21 Oct 2026
0.75/10 mg tablets, Tablet · Cat 5–10 kg Cat 5–10 kg 2 tablets
Give individually with a small amount of food or directly, whole, crushed or dissolved in water. Keep fresh drinking water available. Do not use in pregnancy or lactation, under 10 weeks, below 1 kg, or with ingredient hypersensitivity. Collies, Shelties and Bobtails require veterinary supervision. Use cautiously with hypertension or epilepsy. Do not combine with other macrocyclic-lactone medicines. The longer twice-daily 10-14-day schedule applies only to feline leukaemia, immunodeficiency or coronavirus-enteritis viral-load reduction under veterinary care.
 · treatment: twice daily for 5-7 days, then once daily for 5 days; prevention: once daily for 3-4 days		 treatment: twice daily for 5-7 days, then once daily for 5 days; prevention: once daily for 3-4 days Georgia Yes, veterinary
In force until 26 Jul 2029
Veterinary (National Food Agency)
In the register: არბიმექტინი
№ 000712
Verified on: 21 Oct 2026
0.75/10 mg tablets, Tablet · Cat over 10 kg Cat over 10 kg 1 tablet per 5 kg
Give individually with a small amount of food or directly, whole, crushed or dissolved in water. Keep fresh drinking water available. Do not use in pregnancy or lactation, under 10 weeks, below 1 kg, or with ingredient hypersensitivity. Collies, Shelties and Bobtails require veterinary supervision. Use cautiously with hypertension or epilepsy. Do not combine with other macrocyclic-lactone medicines. The longer twice-daily 10-14-day schedule applies only to feline leukaemia, immunodeficiency or coronavirus-enteritis viral-load reduction under veterinary care.
 · treatment: twice daily for 5-7 days, then once daily for 5 days; prevention: once daily for 3-4 days		 treatment: twice daily for 5-7 days, then once daily for 5 days; prevention: once daily for 3-4 days Georgia Yes, veterinary
In force until 26 Jul 2029
Veterinary (National Food Agency)
In the register: არბიმექტინი
№ 000712
Verified on: 21 Oct 2026
0.75/10 mg tablets, Tablet · Dog 1–2 kg Dog 1–2 kg 1/4 tablet
Give individually with a small amount of food or directly, whole, crushed or dissolved in water. Keep fresh drinking water available. Do not use in pregnancy or lactation, under 10 weeks, below 1 kg, or with ingredient hypersensitivity. Collies, Shelties and Bobtails require veterinary supervision. Use cautiously with hypertension or epilepsy. Do not combine with other macrocyclic-lactone medicines. The longer twice-daily 10-14-day schedule applies only to feline leukaemia, immunodeficiency or coronavirus-enteritis viral-load reduction under veterinary care.
 · treatment: twice daily for 5-7 days, then once daily for 5 days; prevention: once daily for 3-4 days		 treatment: twice daily for 5-7 days, then once daily for 5 days; prevention: once daily for 3-4 days Georgia Yes, veterinary
In force until 26 Jul 2029
Veterinary (National Food Agency)
In the register: არბიმექტინი
№ 000712
Verified on: 21 Oct 2026
0.75/10 mg tablets, Tablet · Dog 2–2.5 kg Dog 2–2.5 kg 1/2 tablet
Give individually with a small amount of food or directly, whole, crushed or dissolved in water. Keep fresh drinking water available. Do not use in pregnancy or lactation, under 10 weeks, below 1 kg, or with ingredient hypersensitivity. Collies, Shelties and Bobtails require veterinary supervision. Use cautiously with hypertension or epilepsy. Do not combine with other macrocyclic-lactone medicines. The longer twice-daily 10-14-day schedule applies only to feline leukaemia, immunodeficiency or coronavirus-enteritis viral-load reduction under veterinary care.
 · treatment: twice daily for 5-7 days, then once daily for 5 days; prevention: once daily for 3-4 days		 treatment: twice daily for 5-7 days, then once daily for 5 days; prevention: once daily for 3-4 days Georgia Yes, veterinary
In force until 26 Jul 2029
Veterinary (National Food Agency)
In the register: არბიმექტინი
№ 000712
Verified on: 21 Oct 2026
0.75/10 mg tablets, Tablet · Dog 2.5–5 kg Dog 2.5–5 kg 1 tablet
Give individually with a small amount of food or directly, whole, crushed or dissolved in water. Keep fresh drinking water available. Do not use in pregnancy or lactation, under 10 weeks, below 1 kg, or with ingredient hypersensitivity. Collies, Shelties and Bobtails require veterinary supervision. Use cautiously with hypertension or epilepsy. Do not combine with other macrocyclic-lactone medicines. The longer twice-daily 10-14-day schedule applies only to feline leukaemia, immunodeficiency or coronavirus-enteritis viral-load reduction under veterinary care.
 · treatment: twice daily for 5-7 days, then once daily for 5 days; prevention: once daily for 3-4 days		 treatment: twice daily for 5-7 days, then once daily for 5 days; prevention: once daily for 3-4 days Georgia Yes, veterinary
In force until 26 Jul 2029
Veterinary (National Food Agency)
In the register: არბიმექტინი
№ 000712
Verified on: 21 Oct 2026
0.75/10 mg tablets, Tablet · Dog 5–10 kg Dog 5–10 kg 2 tablets
Give individually with a small amount of food or directly, whole, crushed or dissolved in water. Keep fresh drinking water available. Do not use in pregnancy or lactation, under 10 weeks, below 1 kg, or with ingredient hypersensitivity. Collies, Shelties and Bobtails require veterinary supervision. Use cautiously with hypertension or epilepsy. Do not combine with other macrocyclic-lactone medicines. The longer twice-daily 10-14-day schedule applies only to feline leukaemia, immunodeficiency or coronavirus-enteritis viral-load reduction under veterinary care.
 · treatment: twice daily for 5-7 days, then once daily for 5 days; prevention: once daily for 3-4 days		 treatment: twice daily for 5-7 days, then once daily for 5 days; prevention: once daily for 3-4 days Georgia Yes, veterinary
In force until 26 Jul 2029
Veterinary (National Food Agency)
In the register: არბიმექტინი
№ 000712
Verified on: 21 Oct 2026
0.75/10 mg tablets, Tablet · Dog over 10 kg Dog over 10 kg 1 tablet per 5 kg
Give individually with a small amount of food or directly, whole, crushed or dissolved in water. Keep fresh drinking water available. Do not use in pregnancy or lactation, under 10 weeks, below 1 kg, or with ingredient hypersensitivity. Collies, Shelties and Bobtails require veterinary supervision. Use cautiously with hypertension or epilepsy. Do not combine with other macrocyclic-lactone medicines. The longer twice-daily 10-14-day schedule applies only to feline leukaemia, immunodeficiency or coronavirus-enteritis viral-load reduction under veterinary care.
 · treatment: twice daily for 5-7 days, then once daily for 5 days; prevention: once daily for 3-4 days		 treatment: twice daily for 5-7 days, then once daily for 5 days; prevention: once daily for 3-4 days Georgia Yes, veterinary
In force until 26 Jul 2029
Veterinary (National Food Agency)
In the register: არბიმექტინი
№ 000712
Verified on: 21 Oct 2026
Details: pack, label wording, sources, registration

Arbimectin 0.75/10 mg tablets, Tablet

N6 for cats and small dogs
vetman assessment
vetman’s 10-point assessment brings together a product’s regulatory credibility, clinical efficacy, safety and practicality. Cost-effectiveness is assessed only when reliable data are available. It is informational and does not replace a veterinarian’s clinical judgment for an individual patient.
Dog Full labelled canine oral scope: prevention of viral disease and adjunct treatment of distemper, adenoviral infection, parvoviral and coronavirus enteritis, bordetellosis and parainfluenza
3.5/10
Poor / unconvincing
vetman assessment

Arbimectin

0.75/10 mg tablets, N6 for cats and small dogs
Assessed clinical scopeDog · Full labelled canine oral scope: prevention of viral disease and adjunct treatment of distemper, adenoviral infection, parvoviral and coronavirus enteritis, bordetellosis and parainfluenza · oral
Care settingVeterinary-selected adjunctive home treatment after diagnosis and standard-of-care planning, with close response and neurologic monitoring
vetman score 3.5/10 Poor / unconvincing
Evidence confidence: Low Georgia: Yes, veterinary · № 000712 · Verified on 21 Oct 2026

The exact registered tablet is identifiable, but its broad antiviral and infection claims are not supported by reliable clinical benefit: the exact trial found no statistically significant advantage. Do not substitute it for vaccination, diagnosis or standard supportive/etiologic care; if used as an adjunct, apply strict ivermectin and ABCB1 risk screening and monitoring.

Regulatory and scientific credibility4.0/10

The exact presentation is currently registered in Georgia and current instructions verify identity, composition and labelled use. However, no EMA/FDA-style public assessment or transparent full dossier was found; umifenovir is reserved for human use and prohibited in animals under EU Regulation 2022/1255; and the only exact-tablet clinical trial is sponsor-linked, reports no statistically significant benefit and still concludes efficacy. The evidence gate therefore applies.

Clinical efficacy2.5/10

The exact 2024 tablet study included 120 dogs across four size strata and four infections; improvement was generally only 0-2 days earlier and no statistically significant group difference was found. The paper nevertheless called the product effective, while current review evidence considers veterinary antiviral activity of ivermectin exploratory and clinically unproven. The broad prevention and treatment scope is therefore not credibly demonstrated.

Safety and tolerability3.5/10

The exact short field study reported no adverse reactions, but it did not establish a safety margin for repeated twice-daily courses or uncommon events. Ivermectin neurotoxicity is exposure- and ABCB1-dependent, especially in susceptible herding breeds; the label excludes puppies under 10 weeks, animals under 1 kg, pregnancy and lactation, and no specific antidote exists.

Clinical practicality4.5/10

Oral administration with food and quarter-tablet increments are feasible at home, but treatment is twice daily for 5-7 days and then daily for 5 days, or twice daily for 10-14 days for selected feline claims. Exact weight-band selection and repeated tablet splitting are required, and one N6 pack is commonly insufficient for a full course.

Full-course cost-effectiveness-

Price was not assessed and is excluded from the overall score.

Important safety and use flags

  • Do not use with hypersensitivity to either component, in animals under 10 weeks or under 1 kg, or during pregnancy or lactation.
  • Do not combine with another macrocyclic lactone. Review all antiparasitics and interacting P-glycoprotein substrates or inhibitors before treatment.
  • Use cautiously in hypertension or epilepsy. Monitor appetite, gastrointestinal signs, behaviour and neurologic status throughout the repeated course.
  • Depression, hypersalivation, anorexia, diarrhoea, tremor or other neurologic signs may indicate excess exposure. Stop treatment and provide prompt supportive care; no specific antidote is available.
  • The exact tablet trial found no statistically significant clinical advantage, and independent exact-product replication was not found. Do not interpret the broad label as proof of antiviral efficacy.
  • This is labelled only as adjunctive treatment. It must not delay pathogen-directed therapy, fluid and nutritional support, isolation, analgesia or other standard care appropriate to the diagnosis.
  • The prevention claim is not a substitute for evidence-based vaccination, infection control or exposure management.
  • Use the exact strength and weight-band table and quarter tablets accurately. Full treatment commonly requires multiple packs; verify that the complete course can be supplied before starting.
  • Umifenovir is reserved for human use and may not be used in animals in the European Union under Regulation (EU) 2022/1255. Georgian registration does not remove this major international regulatory and antimicrobial-stewardship conflict.
  • Collies, Shelties, Old English Sheepdogs and related herding breeds may have ABCB1-associated ivermectin sensitivity. Use only after veterinary risk assessment, preferably with known ABCB1 status.
Assessment sources
  1. Arbimectin PVR-3-21.20/035972026
  2. Agrobioprom Arbimectin2026
  3. Georgia NFA register 20262026
  4. Arbimectin trial2024
  5. Ivermectin review2026
  6. Ivermectin toxicity2026
  7. ABCB1 review2023
  8. EU Regulation 20222022
Assessed: 22 Oct 2026The overall score uses 25/25/25/15/10 weights. An unassessed price is excluded and the remaining weights are proportionally renormalised.
Cat Full labelled feline oral scope: prevention of viral disease; adjunct treatment of panleukopenia, herpesviral rhinotracheitis, calicivirus, chlamydiosis and mycoplasmosis; viral-load reduction in FeLV, FIV and coronavirus enteritis
3.4/10
Poor / unconvincing
vetman assessment

Arbimectin

0.75/10 mg tablets, N6 for cats and small dogs
Assessed clinical scopeCat · Full labelled feline oral scope: prevention of viral disease; adjunct treatment of panleukopenia, herpesviral rhinotracheitis, calicivirus, chlamydiosis and mycoplasmosis; viral-load reduction in FeLV, FIV and coronavirus enteritis · oral
Care settingVeterinary-selected adjunctive home treatment after diagnosis and standard-of-care planning, with close response and neurologic monitoring
vetman score 3.4/10 Poor / unconvincing
Evidence confidence: Low Georgia: Yes, veterinary · № 000712 · Verified on 21 Oct 2026

The exact registered tablet is identifiable, but its broad antiviral and infection claims are not supported by reliable clinical benefit: the exact trial was non-significant and the positive calicivirus paper used another formulation. Do not substitute it for vaccination, diagnosis or standard supportive/etiologic care; if used as an adjunct, apply strict ivermectin risk screening and monitoring.

Regulatory and scientific credibility4.0/10

The exact presentation is currently registered in Georgia and current instructions verify identity, composition and labelled use. However, no EMA/FDA-style public assessment or transparent full dossier was found; umifenovir is reserved for human use and prohibited in animals under EU Regulation 2022/1255; and the only exact-tablet clinical trial is sponsor-linked, reports no statistically significant benefit and still concludes efficacy. The evidence gate therefore applies.

Clinical efficacy2.5/10

The exact 2024 tablet study included 80 cats but reported no statistically significant acceleration of improvement across five infections. A second positive calicivirus report used an intramuscular 7% solution rather than these tablets and had non-randomised, poorly described groups. Current review evidence considers veterinary antiviral activity of ivermectin exploratory and clinically unproven; the broad prevention and FeLV/FIV claims remain unsupported.

Safety and tolerability3.0/10

The exact short field study reported no adverse reactions, but it did not establish a safety margin for repeated twice-daily courses or uncommon events. Ivermectin neurotoxicity is exposure- and ABCB1-dependent, loss-of-function variants also occur in cats, the label excludes kittens under 10 weeks, animals under 1 kg, pregnancy and lactation, and no specific antidote exists.

Clinical practicality4.5/10

Oral administration with food and quarter-tablet increments are feasible at home, but treatment is twice daily for 5-7 days and then daily for 5 days, or twice daily for 10-14 days for selected feline claims. Exact weight-band selection and repeated tablet splitting are required, and one N6 pack is commonly insufficient for a full course.

Full-course cost-effectiveness-

Price was not assessed and is excluded from the overall score.

Important safety and use flags

  • Do not use with hypersensitivity to either component, in animals under 10 weeks or under 1 kg, or during pregnancy or lactation.
  • Do not combine with another macrocyclic lactone. Review all antiparasitics and interacting P-glycoprotein substrates or inhibitors before treatment.
  • Use cautiously in hypertension or epilepsy. Monitor appetite, gastrointestinal signs, behaviour and neurologic status throughout the repeated course.
  • Depression, hypersalivation, anorexia, diarrhoea, tremor or other neurologic signs may indicate excess exposure. Stop treatment and provide prompt supportive care; no specific antidote is available.
  • The exact tablet trial found no statistically significant clinical advantage, and independent exact-product replication was not found. Do not interpret the broad label as proof of antiviral efficacy.
  • This is labelled only as adjunctive treatment. It must not delay pathogen-directed therapy, fluid and nutritional support, isolation, analgesia or other standard care appropriate to the diagnosis.
  • The prevention claim is not a substitute for evidence-based vaccination, infection control or exposure management.
  • Use the exact strength and weight-band table and quarter tablets accurately. Full treatment commonly requires multiple packs; verify that the complete course can be supplied before starting.
  • Umifenovir is reserved for human use and may not be used in animals in the European Union under Regulation (EU) 2022/1255. Georgian registration does not remove this major international regulatory and antimicrobial-stewardship conflict.
  • ABCB1 loss-of-function variants and ivermectin neurotoxicity also occur in cats. Individual susceptibility is not reliably excluded by breed or prior uneventful exposure.
Assessment sources
  1. Arbimectin PVR-3-21.20/035972026
  2. Agrobioprom Arbimectin2026
  3. Georgia NFA register 20262026
  4. Arbimectin trial2024
  5. Arbimectin FCV study2024
  6. Ivermectin review2026
  7. Ivermectin toxicity2026
  8. ABCB1 review2023
  9. EU Regulation 20222022
Assessed: 22 Oct 2026The overall score uses 25/25/25/15/10 weights. An unassessed price is excluded and the remaining weights are proportionally renormalised.
Composition / strength
Ivermectin0.75 mg/tablet Umifenovir hydrochloride10 mg/tablet
Formulation Type
Tablet
Administration route
By mouth
Manufacturer
Agrobioprom JSC · Russia
Manufacturer (register)
Agrobioprom LTD, Russia
Manufacturer and country as in the veterinary medicines register (National Food Agency), row 1201, 19 Oct 2026.
Source: NFA veterinary medicines register ↗
Registration
Georgia Yes, veterinary
In force until 26 Jul 2029
Veterinary (National Food Agency)
In the register: არბიმექტინი
№ 000712
Verified on: 21 Oct 2026
Controlled in Georgia
Unknown
DoseSpeciesWeightRouteFrequencySource
1/4 tablet
Give individually with a small amount of food or directly, whole, crushed or dissolved in water. Keep fresh drinking water available. Do not use in pregnancy or lactation, under 10 weeks, below 1 kg, or with ingredient hypersensitivity. Collies, Shelties and Bobtails require veterinary supervision. Use cautiously with hypertension or epilepsy. Do not combine with other macrocyclic-lactone medicines. The longer twice-daily 10-14-day schedule applies only to feline leukaemia, immunodeficiency or coronavirus-enteritis viral-load reduction under veterinary care.
 Cat 1–2 kg By mouth treatment: twice daily for 5-7 days, then once daily for 5 days; prevention: once daily for 3-4 days
Arbimectin PVR-3-21.20/03597
Official product label (SPC)
Approved by a medicines regulator as part of the product's authorisation. It applies to that product as authorised there.
Arbimectin tablets - complete registration-linked instruction
Russian veterinary register mirror and current manufacturer catalogue, 2026
1/2 tablet
Give individually with a small amount of food or directly, whole, crushed or dissolved in water. Keep fresh drinking water available. Do not use in pregnancy or lactation, under 10 weeks, below 1 kg, or with ingredient hypersensitivity. Collies, Shelties and Bobtails require veterinary supervision. Use cautiously with hypertension or epilepsy. Do not combine with other macrocyclic-lactone medicines. The longer twice-daily 10-14-day schedule applies only to feline leukaemia, immunodeficiency or coronavirus-enteritis viral-load reduction under veterinary care.
 Cat 2–2.5 kg By mouth treatment: twice daily for 5-7 days, then once daily for 5 days; prevention: once daily for 3-4 days
Arbimectin PVR-3-21.20/03597
Official product label (SPC)
Approved by a medicines regulator as part of the product's authorisation. It applies to that product as authorised there.
Arbimectin tablets - complete registration-linked instruction
Russian veterinary register mirror and current manufacturer catalogue, 2026
1 tablet
Give individually with a small amount of food or directly, whole, crushed or dissolved in water. Keep fresh drinking water available. Do not use in pregnancy or lactation, under 10 weeks, below 1 kg, or with ingredient hypersensitivity. Collies, Shelties and Bobtails require veterinary supervision. Use cautiously with hypertension or epilepsy. Do not combine with other macrocyclic-lactone medicines. The longer twice-daily 10-14-day schedule applies only to feline leukaemia, immunodeficiency or coronavirus-enteritis viral-load reduction under veterinary care.
 Cat 2.5–5 kg By mouth treatment: twice daily for 5-7 days, then once daily for 5 days; prevention: once daily for 3-4 days
Arbimectin PVR-3-21.20/03597
Official product label (SPC)
Approved by a medicines regulator as part of the product's authorisation. It applies to that product as authorised there.
Arbimectin tablets - complete registration-linked instruction
Russian veterinary register mirror and current manufacturer catalogue, 2026
2 tablets
Give individually with a small amount of food or directly, whole, crushed or dissolved in water. Keep fresh drinking water available. Do not use in pregnancy or lactation, under 10 weeks, below 1 kg, or with ingredient hypersensitivity. Collies, Shelties and Bobtails require veterinary supervision. Use cautiously with hypertension or epilepsy. Do not combine with other macrocyclic-lactone medicines. The longer twice-daily 10-14-day schedule applies only to feline leukaemia, immunodeficiency or coronavirus-enteritis viral-load reduction under veterinary care.
 Cat 5–10 kg By mouth treatment: twice daily for 5-7 days, then once daily for 5 days; prevention: once daily for 3-4 days
Arbimectin PVR-3-21.20/03597
Official product label (SPC)
Approved by a medicines regulator as part of the product's authorisation. It applies to that product as authorised there.
Arbimectin tablets - complete registration-linked instruction
Russian veterinary register mirror and current manufacturer catalogue, 2026
1 tablet per 5 kg
Give individually with a small amount of food or directly, whole, crushed or dissolved in water. Keep fresh drinking water available. Do not use in pregnancy or lactation, under 10 weeks, below 1 kg, or with ingredient hypersensitivity. Collies, Shelties and Bobtails require veterinary supervision. Use cautiously with hypertension or epilepsy. Do not combine with other macrocyclic-lactone medicines. The longer twice-daily 10-14-day schedule applies only to feline leukaemia, immunodeficiency or coronavirus-enteritis viral-load reduction under veterinary care.
 Cat over 10 kg By mouth treatment: twice daily for 5-7 days, then once daily for 5 days; prevention: once daily for 3-4 days
Arbimectin PVR-3-21.20/03597
Official product label (SPC)
Approved by a medicines regulator as part of the product's authorisation. It applies to that product as authorised there.
Arbimectin tablets - complete registration-linked instruction
Russian veterinary register mirror and current manufacturer catalogue, 2026
1/4 tablet
Give individually with a small amount of food or directly, whole, crushed or dissolved in water. Keep fresh drinking water available. Do not use in pregnancy or lactation, under 10 weeks, below 1 kg, or with ingredient hypersensitivity. Collies, Shelties and Bobtails require veterinary supervision. Use cautiously with hypertension or epilepsy. Do not combine with other macrocyclic-lactone medicines. The longer twice-daily 10-14-day schedule applies only to feline leukaemia, immunodeficiency or coronavirus-enteritis viral-load reduction under veterinary care.
 Dog 1–2 kg By mouth treatment: twice daily for 5-7 days, then once daily for 5 days; prevention: once daily for 3-4 days
Arbimectin PVR-3-21.20/03597
Official product label (SPC)
Approved by a medicines regulator as part of the product's authorisation. It applies to that product as authorised there.
Arbimectin tablets - complete registration-linked instruction
Russian veterinary register mirror and current manufacturer catalogue, 2026
1/2 tablet
Give individually with a small amount of food or directly, whole, crushed or dissolved in water. Keep fresh drinking water available. Do not use in pregnancy or lactation, under 10 weeks, below 1 kg, or with ingredient hypersensitivity. Collies, Shelties and Bobtails require veterinary supervision. Use cautiously with hypertension or epilepsy. Do not combine with other macrocyclic-lactone medicines. The longer twice-daily 10-14-day schedule applies only to feline leukaemia, immunodeficiency or coronavirus-enteritis viral-load reduction under veterinary care.
 Dog 2–2.5 kg By mouth treatment: twice daily for 5-7 days, then once daily for 5 days; prevention: once daily for 3-4 days
Arbimectin PVR-3-21.20/03597
Official product label (SPC)
Approved by a medicines regulator as part of the product's authorisation. It applies to that product as authorised there.
Arbimectin tablets - complete registration-linked instruction
Russian veterinary register mirror and current manufacturer catalogue, 2026
1 tablet
Give individually with a small amount of food or directly, whole, crushed or dissolved in water. Keep fresh drinking water available. Do not use in pregnancy or lactation, under 10 weeks, below 1 kg, or with ingredient hypersensitivity. Collies, Shelties and Bobtails require veterinary supervision. Use cautiously with hypertension or epilepsy. Do not combine with other macrocyclic-lactone medicines. The longer twice-daily 10-14-day schedule applies only to feline leukaemia, immunodeficiency or coronavirus-enteritis viral-load reduction under veterinary care.
 Dog 2.5–5 kg By mouth treatment: twice daily for 5-7 days, then once daily for 5 days; prevention: once daily for 3-4 days
Arbimectin PVR-3-21.20/03597
Official product label (SPC)
Approved by a medicines regulator as part of the product's authorisation. It applies to that product as authorised there.
Arbimectin tablets - complete registration-linked instruction
Russian veterinary register mirror and current manufacturer catalogue, 2026
2 tablets
Give individually with a small amount of food or directly, whole, crushed or dissolved in water. Keep fresh drinking water available. Do not use in pregnancy or lactation, under 10 weeks, below 1 kg, or with ingredient hypersensitivity. Collies, Shelties and Bobtails require veterinary supervision. Use cautiously with hypertension or epilepsy. Do not combine with other macrocyclic-lactone medicines. The longer twice-daily 10-14-day schedule applies only to feline leukaemia, immunodeficiency or coronavirus-enteritis viral-load reduction under veterinary care.
 Dog 5–10 kg By mouth treatment: twice daily for 5-7 days, then once daily for 5 days; prevention: once daily for 3-4 days
Arbimectin PVR-3-21.20/03597
Official product label (SPC)
Approved by a medicines regulator as part of the product's authorisation. It applies to that product as authorised there.
Arbimectin tablets - complete registration-linked instruction
Russian veterinary register mirror and current manufacturer catalogue, 2026
1 tablet per 5 kg
Give individually with a small amount of food or directly, whole, crushed or dissolved in water. Keep fresh drinking water available. Do not use in pregnancy or lactation, under 10 weeks, below 1 kg, or with ingredient hypersensitivity. Collies, Shelties and Bobtails require veterinary supervision. Use cautiously with hypertension or epilepsy. Do not combine with other macrocyclic-lactone medicines. The longer twice-daily 10-14-day schedule applies only to feline leukaemia, immunodeficiency or coronavirus-enteritis viral-load reduction under veterinary care.
 Dog over 10 kg By mouth treatment: twice daily for 5-7 days, then once daily for 5 days; prevention: once daily for 3-4 days
Arbimectin PVR-3-21.20/03597
Official product label (SPC)
Approved by a medicines regulator as part of the product's authorisation. It applies to that product as authorised there.
Arbimectin tablets - complete registration-linked instruction
Russian veterinary register mirror and current manufacturer catalogue, 2026
1.5/20 mg tablets, Tablet · Dog 1–2.5 kg Dog 1–2.5 kg 1/4 tablet
Give individually with a small amount of food or directly, whole, crushed or dissolved in water. Keep fresh drinking water available. Do not use in pregnancy or lactation, under 10 weeks, below 1 kg, or with ingredient hypersensitivity. Collies, Shelties and Bobtails require veterinary supervision. Use cautiously with hypertension or epilepsy. Do not combine with other macrocyclic-lactone medicines. The longer twice-daily 10-14-day schedule applies only to feline leukaemia, immunodeficiency or coronavirus-enteritis viral-load reduction under veterinary care.
 · treatment: twice daily for 5-7 days, then once daily for 5 days; prevention: once daily for 3-4 days		 treatment: twice daily for 5-7 days, then once daily for 5 days; prevention: once daily for 3-4 days Georgia Yes, veterinary
In force until 26 Jul 2029
Veterinary (National Food Agency)
In the register: არბიმექტინი
№ 000711
Verified on: 21 Oct 2026
1.5/20 mg tablets, Tablet · Dog 2.5–5 kg Dog 2.5–5 kg 1/2 tablet
Give individually with a small amount of food or directly, whole, crushed or dissolved in water. Keep fresh drinking water available. Do not use in pregnancy or lactation, under 10 weeks, below 1 kg, or with ingredient hypersensitivity. Collies, Shelties and Bobtails require veterinary supervision. Use cautiously with hypertension or epilepsy. Do not combine with other macrocyclic-lactone medicines. The longer twice-daily 10-14-day schedule applies only to feline leukaemia, immunodeficiency or coronavirus-enteritis viral-load reduction under veterinary care.
 · treatment: twice daily for 5-7 days, then once daily for 5 days; prevention: once daily for 3-4 days		 treatment: twice daily for 5-7 days, then once daily for 5 days; prevention: once daily for 3-4 days Georgia Yes, veterinary
In force until 26 Jul 2029
Veterinary (National Food Agency)
In the register: არბიმექტინი
№ 000711
Verified on: 21 Oct 2026
1.5/20 mg tablets, Tablet · Dog 5–10 kg Dog 5–10 kg 1 tablet
Give individually with a small amount of food or directly, whole, crushed or dissolved in water. Keep fresh drinking water available. Do not use in pregnancy or lactation, under 10 weeks, below 1 kg, or with ingredient hypersensitivity. Collies, Shelties and Bobtails require veterinary supervision. Use cautiously with hypertension or epilepsy. Do not combine with other macrocyclic-lactone medicines. The longer twice-daily 10-14-day schedule applies only to feline leukaemia, immunodeficiency or coronavirus-enteritis viral-load reduction under veterinary care.
 · treatment: twice daily for 5-7 days, then once daily for 5 days; prevention: once daily for 3-4 days		 treatment: twice daily for 5-7 days, then once daily for 5 days; prevention: once daily for 3-4 days Georgia Yes, veterinary
In force until 26 Jul 2029
Veterinary (National Food Agency)
In the register: არბიმექტინი
№ 000711
Verified on: 21 Oct 2026
1.5/20 mg tablets, Tablet · Dog 10–15 kg Dog 10–15 kg 1 1/2 tablets
Give individually with a small amount of food or directly, whole, crushed or dissolved in water. Keep fresh drinking water available. Do not use in pregnancy or lactation, under 10 weeks, below 1 kg, or with ingredient hypersensitivity. Collies, Shelties and Bobtails require veterinary supervision. Use cautiously with hypertension or epilepsy. Do not combine with other macrocyclic-lactone medicines. The longer twice-daily 10-14-day schedule applies only to feline leukaemia, immunodeficiency or coronavirus-enteritis viral-load reduction under veterinary care.
 · treatment: twice daily for 5-7 days, then once daily for 5 days; prevention: once daily for 3-4 days		 treatment: twice daily for 5-7 days, then once daily for 5 days; prevention: once daily for 3-4 days Georgia Yes, veterinary
In force until 26 Jul 2029
Veterinary (National Food Agency)
In the register: არბიმექტინი
№ 000711
Verified on: 21 Oct 2026
1.5/20 mg tablets, Tablet · Dog 15–20 kg Dog 15–20 kg 2 tablets
Give individually with a small amount of food or directly, whole, crushed or dissolved in water. Keep fresh drinking water available. Do not use in pregnancy or lactation, under 10 weeks, below 1 kg, or with ingredient hypersensitivity. Collies, Shelties and Bobtails require veterinary supervision. Use cautiously with hypertension or epilepsy. Do not combine with other macrocyclic-lactone medicines. The longer twice-daily 10-14-day schedule applies only to feline leukaemia, immunodeficiency or coronavirus-enteritis viral-load reduction under veterinary care.
 · treatment: twice daily for 5-7 days, then once daily for 5 days; prevention: once daily for 3-4 days		 treatment: twice daily for 5-7 days, then once daily for 5 days; prevention: once daily for 3-4 days Georgia Yes, veterinary
In force until 26 Jul 2029
Veterinary (National Food Agency)
In the register: არბიმექტინი
№ 000711
Verified on: 21 Oct 2026
1.5/20 mg tablets, Tablet · Dog over 20 kg Dog over 20 kg 1 tablet per 10 kg
Give individually with a small amount of food or directly, whole, crushed or dissolved in water. Keep fresh drinking water available. Do not use in pregnancy or lactation, under 10 weeks, below 1 kg, or with ingredient hypersensitivity. Collies, Shelties and Bobtails require veterinary supervision. Use cautiously with hypertension or epilepsy. Do not combine with other macrocyclic-lactone medicines. The longer twice-daily 10-14-day schedule applies only to feline leukaemia, immunodeficiency or coronavirus-enteritis viral-load reduction under veterinary care.
 · treatment: twice daily for 5-7 days, then once daily for 5 days; prevention: once daily for 3-4 days		 treatment: twice daily for 5-7 days, then once daily for 5 days; prevention: once daily for 3-4 days Georgia Yes, veterinary
In force until 26 Jul 2029
Veterinary (National Food Agency)
In the register: არბიმექტინი
№ 000711
Verified on: 21 Oct 2026
Details: pack, label wording, sources, registration

Arbimectin 1.5/20 mg tablets, Tablet

N6 for medium dogs
vetman assessment
vetman’s 10-point assessment brings together a product’s regulatory credibility, clinical efficacy, safety and practicality. Cost-effectiveness is assessed only when reliable data are available. It is informational and does not replace a veterinarian’s clinical judgment for an individual patient.
Dog
3.5/10
Poor / unconvincing
vetman assessment

Arbimectin

1.5/20 mg tablets, N6 for medium dogs
Assessed clinical scopeDog · Full labelled canine oral scope: prevention of viral disease and adjunct treatment of distemper, adenoviral infection, parvoviral and coronavirus enteritis, bordetellosis and parainfluenza · oral
Care settingVeterinary-selected adjunctive home treatment after diagnosis and standard-of-care planning, with close response and neurologic monitoring
vetman score 3.5/10 Poor / unconvincing
Evidence confidence: Low Georgia: Yes, veterinary · № 000711 · Verified on 21 Oct 2026

The exact registered tablet is identifiable, but its broad antiviral and infection claims are not supported by reliable clinical benefit: the exact trial found no statistically significant advantage. Do not substitute it for vaccination, diagnosis or standard supportive/etiologic care; if used as an adjunct, apply strict ivermectin and ABCB1 risk screening and monitoring.

Regulatory and scientific credibility4.0/10

The exact presentation is currently registered in Georgia and current instructions verify identity, composition and labelled use. However, no EMA/FDA-style public assessment or transparent full dossier was found; umifenovir is reserved for human use and prohibited in animals under EU Regulation 2022/1255; and the only exact-tablet clinical trial is sponsor-linked, reports no statistically significant benefit and still concludes efficacy. The evidence gate therefore applies.

Clinical efficacy2.5/10

The exact 2024 tablet study included 120 dogs across four size strata and four infections; improvement was generally only 0-2 days earlier and no statistically significant group difference was found. The paper nevertheless called the product effective, while current review evidence considers veterinary antiviral activity of ivermectin exploratory and clinically unproven. The broad prevention and treatment scope is therefore not credibly demonstrated.

Safety and tolerability3.5/10

The exact short field study reported no adverse reactions, but it did not establish a safety margin for repeated twice-daily courses or uncommon events. Ivermectin neurotoxicity is exposure- and ABCB1-dependent, especially in susceptible herding breeds; the label excludes puppies under 10 weeks, animals under 1 kg, pregnancy and lactation, and no specific antidote exists.

Clinical practicality4.5/10

Oral administration with food and quarter-tablet increments are feasible at home, but treatment is twice daily for 5-7 days and then daily for 5 days, or twice daily for 10-14 days for selected feline claims. Exact weight-band selection and repeated tablet splitting are required, and one N6 pack is commonly insufficient for a full course.

Full-course cost-effectiveness-

Price was not assessed and is excluded from the overall score.

Important safety and use flags

  • Do not use with hypersensitivity to either component, in animals under 10 weeks or under 1 kg, or during pregnancy or lactation.
  • Do not combine with another macrocyclic lactone. Review all antiparasitics and interacting P-glycoprotein substrates or inhibitors before treatment.
  • Use cautiously in hypertension or epilepsy. Monitor appetite, gastrointestinal signs, behaviour and neurologic status throughout the repeated course.
  • Depression, hypersalivation, anorexia, diarrhoea, tremor or other neurologic signs may indicate excess exposure. Stop treatment and provide prompt supportive care; no specific antidote is available.
  • The exact tablet trial found no statistically significant clinical advantage, and independent exact-product replication was not found. Do not interpret the broad label as proof of antiviral efficacy.
  • This is labelled only as adjunctive treatment. It must not delay pathogen-directed therapy, fluid and nutritional support, isolation, analgesia or other standard care appropriate to the diagnosis.
  • The prevention claim is not a substitute for evidence-based vaccination, infection control or exposure management.
  • Use the exact strength and weight-band table and quarter tablets accurately. Full treatment commonly requires multiple packs; verify that the complete course can be supplied before starting.
  • Umifenovir is reserved for human use and may not be used in animals in the European Union under Regulation (EU) 2022/1255. Georgian registration does not remove this major international regulatory and antimicrobial-stewardship conflict.
  • Collies, Shelties, Old English Sheepdogs and related herding breeds may have ABCB1-associated ivermectin sensitivity. Use only after veterinary risk assessment, preferably with known ABCB1 status.
Assessment sources
  1. Arbimectin PVR-3-21.20/035972026
  2. Agrobioprom Arbimectin2026
  3. Georgia NFA register 20262026
  4. Arbimectin trial2024
  5. Ivermectin review2026
  6. Ivermectin toxicity2026
  7. ABCB1 review2023
  8. EU Regulation 20222022
Assessed: 22 Oct 2026The overall score uses 25/25/25/15/10 weights. An unassessed price is excluded and the remaining weights are proportionally renormalised.
Composition / strength
Ivermectin1.5 mg/tablet Umifenovir hydrochloride20 mg/tablet
Formulation Type
Tablet
Administration route
By mouth
Manufacturer
Agrobioprom JSC · Russia
Manufacturer (register)
Agrobioprom LTD, Russia
Manufacturer and country as in the veterinary medicines register (National Food Agency), row 1200, 19 Oct 2026.
Source: NFA veterinary medicines register ↗
Registration
Georgia Yes, veterinary
In force until 26 Jul 2029
Veterinary (National Food Agency)
In the register: არბიმექტინი
№ 000711
Verified on: 21 Oct 2026
Controlled in Georgia
Unknown
DoseSpeciesWeightRouteFrequencySource
1/4 tablet
Give individually with a small amount of food or directly, whole, crushed or dissolved in water. Keep fresh drinking water available. Do not use in pregnancy or lactation, under 10 weeks, below 1 kg, or with ingredient hypersensitivity. Collies, Shelties and Bobtails require veterinary supervision. Use cautiously with hypertension or epilepsy. Do not combine with other macrocyclic-lactone medicines. The longer twice-daily 10-14-day schedule applies only to feline leukaemia, immunodeficiency or coronavirus-enteritis viral-load reduction under veterinary care.
 Dog 1–2.5 kg By mouth treatment: twice daily for 5-7 days, then once daily for 5 days; prevention: once daily for 3-4 days
Arbimectin PVR-3-21.20/03597
Official product label (SPC)
Approved by a medicines regulator as part of the product's authorisation. It applies to that product as authorised there.
Arbimectin tablets - complete registration-linked instruction
Russian veterinary register mirror and current manufacturer catalogue, 2026
1/2 tablet
Give individually with a small amount of food or directly, whole, crushed or dissolved in water. Keep fresh drinking water available. Do not use in pregnancy or lactation, under 10 weeks, below 1 kg, or with ingredient hypersensitivity. Collies, Shelties and Bobtails require veterinary supervision. Use cautiously with hypertension or epilepsy. Do not combine with other macrocyclic-lactone medicines. The longer twice-daily 10-14-day schedule applies only to feline leukaemia, immunodeficiency or coronavirus-enteritis viral-load reduction under veterinary care.
 Dog 2.5–5 kg By mouth treatment: twice daily for 5-7 days, then once daily for 5 days; prevention: once daily for 3-4 days
Arbimectin PVR-3-21.20/03597
Official product label (SPC)
Approved by a medicines regulator as part of the product's authorisation. It applies to that product as authorised there.
Arbimectin tablets - complete registration-linked instruction
Russian veterinary register mirror and current manufacturer catalogue, 2026
1 tablet
Give individually with a small amount of food or directly, whole, crushed or dissolved in water. Keep fresh drinking water available. Do not use in pregnancy or lactation, under 10 weeks, below 1 kg, or with ingredient hypersensitivity. Collies, Shelties and Bobtails require veterinary supervision. Use cautiously with hypertension or epilepsy. Do not combine with other macrocyclic-lactone medicines. The longer twice-daily 10-14-day schedule applies only to feline leukaemia, immunodeficiency or coronavirus-enteritis viral-load reduction under veterinary care.
 Dog 5–10 kg By mouth treatment: twice daily for 5-7 days, then once daily for 5 days; prevention: once daily for 3-4 days
Arbimectin PVR-3-21.20/03597
Official product label (SPC)
Approved by a medicines regulator as part of the product's authorisation. It applies to that product as authorised there.
Arbimectin tablets - complete registration-linked instruction
Russian veterinary register mirror and current manufacturer catalogue, 2026
1 1/2 tablets
Give individually with a small amount of food or directly, whole, crushed or dissolved in water. Keep fresh drinking water available. Do not use in pregnancy or lactation, under 10 weeks, below 1 kg, or with ingredient hypersensitivity. Collies, Shelties and Bobtails require veterinary supervision. Use cautiously with hypertension or epilepsy. Do not combine with other macrocyclic-lactone medicines. The longer twice-daily 10-14-day schedule applies only to feline leukaemia, immunodeficiency or coronavirus-enteritis viral-load reduction under veterinary care.
 Dog 10–15 kg By mouth treatment: twice daily for 5-7 days, then once daily for 5 days; prevention: once daily for 3-4 days
Arbimectin PVR-3-21.20/03597
Official product label (SPC)
Approved by a medicines regulator as part of the product's authorisation. It applies to that product as authorised there.
Arbimectin tablets - complete registration-linked instruction
Russian veterinary register mirror and current manufacturer catalogue, 2026
2 tablets
Give individually with a small amount of food or directly, whole, crushed or dissolved in water. Keep fresh drinking water available. Do not use in pregnancy or lactation, under 10 weeks, below 1 kg, or with ingredient hypersensitivity. Collies, Shelties and Bobtails require veterinary supervision. Use cautiously with hypertension or epilepsy. Do not combine with other macrocyclic-lactone medicines. The longer twice-daily 10-14-day schedule applies only to feline leukaemia, immunodeficiency or coronavirus-enteritis viral-load reduction under veterinary care.
 Dog 15–20 kg By mouth treatment: twice daily for 5-7 days, then once daily for 5 days; prevention: once daily for 3-4 days
Arbimectin PVR-3-21.20/03597
Official product label (SPC)
Approved by a medicines regulator as part of the product's authorisation. It applies to that product as authorised there.
Arbimectin tablets - complete registration-linked instruction
Russian veterinary register mirror and current manufacturer catalogue, 2026
1 tablet per 10 kg
Give individually with a small amount of food or directly, whole, crushed or dissolved in water. Keep fresh drinking water available. Do not use in pregnancy or lactation, under 10 weeks, below 1 kg, or with ingredient hypersensitivity. Collies, Shelties and Bobtails require veterinary supervision. Use cautiously with hypertension or epilepsy. Do not combine with other macrocyclic-lactone medicines. The longer twice-daily 10-14-day schedule applies only to feline leukaemia, immunodeficiency or coronavirus-enteritis viral-load reduction under veterinary care.
 Dog over 20 kg By mouth treatment: twice daily for 5-7 days, then once daily for 5 days; prevention: once daily for 3-4 days
Arbimectin PVR-3-21.20/03597
Official product label (SPC)
Approved by a medicines regulator as part of the product's authorisation. It applies to that product as authorised there.
Arbimectin tablets - complete registration-linked instruction
Russian veterinary register mirror and current manufacturer catalogue, 2026
3/40 mg tablets, Tablet · Dog 1–10 kg Dog 1–10 kg 1/2 tablet
Give individually with a small amount of food or directly, whole, crushed or dissolved in water. Keep fresh drinking water available. Do not use in pregnancy or lactation, under 10 weeks, below 1 kg, or with ingredient hypersensitivity. Collies, Shelties and Bobtails require veterinary supervision. Use cautiously with hypertension or epilepsy. Do not combine with other macrocyclic-lactone medicines. The longer twice-daily 10-14-day schedule applies only to feline leukaemia, immunodeficiency or coronavirus-enteritis viral-load reduction under veterinary care.
 · treatment: twice daily for 5-7 days, then once daily for 5 days; prevention: once daily for 3-4 days		 treatment: twice daily for 5-7 days, then once daily for 5 days; prevention: once daily for 3-4 days Georgia Yes, veterinary
In force until 26 Jul 2029
Veterinary (National Food Agency)
In the register: არბიმექტინი
№ 000709
Verified on: 21 Oct 2026
3/40 mg tablets, Tablet · Dog 10–20 kg Dog 10–20 kg 1 tablet
Give individually with a small amount of food or directly, whole, crushed or dissolved in water. Keep fresh drinking water available. Do not use in pregnancy or lactation, under 10 weeks, below 1 kg, or with ingredient hypersensitivity. Collies, Shelties and Bobtails require veterinary supervision. Use cautiously with hypertension or epilepsy. Do not combine with other macrocyclic-lactone medicines. The longer twice-daily 10-14-day schedule applies only to feline leukaemia, immunodeficiency or coronavirus-enteritis viral-load reduction under veterinary care.
 · treatment: twice daily for 5-7 days, then once daily for 5 days; prevention: once daily for 3-4 days		 treatment: twice daily for 5-7 days, then once daily for 5 days; prevention: once daily for 3-4 days Georgia Yes, veterinary
In force until 26 Jul 2029
Veterinary (National Food Agency)
In the register: არბიმექტინი
№ 000709
Verified on: 21 Oct 2026
3/40 mg tablets, Tablet · Dog 20–30 kg Dog 20–30 kg 1 1/2 tablets
Give individually with a small amount of food or directly, whole, crushed or dissolved in water. Keep fresh drinking water available. Do not use in pregnancy or lactation, under 10 weeks, below 1 kg, or with ingredient hypersensitivity. Collies, Shelties and Bobtails require veterinary supervision. Use cautiously with hypertension or epilepsy. Do not combine with other macrocyclic-lactone medicines. The longer twice-daily 10-14-day schedule applies only to feline leukaemia, immunodeficiency or coronavirus-enteritis viral-load reduction under veterinary care.
 · treatment: twice daily for 5-7 days, then once daily for 5 days; prevention: once daily for 3-4 days		 treatment: twice daily for 5-7 days, then once daily for 5 days; prevention: once daily for 3-4 days Georgia Yes, veterinary
In force until 26 Jul 2029
Veterinary (National Food Agency)
In the register: არბიმექტინი
№ 000709
Verified on: 21 Oct 2026
3/40 mg tablets, Tablet · Dog 30–40 kg Dog 30–40 kg 2 tablets
Give individually with a small amount of food or directly, whole, crushed or dissolved in water. Keep fresh drinking water available. Do not use in pregnancy or lactation, under 10 weeks, below 1 kg, or with ingredient hypersensitivity. Collies, Shelties and Bobtails require veterinary supervision. Use cautiously with hypertension or epilepsy. Do not combine with other macrocyclic-lactone medicines. The longer twice-daily 10-14-day schedule applies only to feline leukaemia, immunodeficiency or coronavirus-enteritis viral-load reduction under veterinary care.
 · treatment: twice daily for 5-7 days, then once daily for 5 days; prevention: once daily for 3-4 days		 treatment: twice daily for 5-7 days, then once daily for 5 days; prevention: once daily for 3-4 days Georgia Yes, veterinary
In force until 26 Jul 2029
Veterinary (National Food Agency)
In the register: არბიმექტინი
№ 000709
Verified on: 21 Oct 2026
3/40 mg tablets, Tablet · Dog over 40 kg Dog over 40 kg 1 tablet per 20 kg
Give individually with a small amount of food or directly, whole, crushed or dissolved in water. Keep fresh drinking water available. Do not use in pregnancy or lactation, under 10 weeks, below 1 kg, or with ingredient hypersensitivity. Collies, Shelties and Bobtails require veterinary supervision. Use cautiously with hypertension or epilepsy. Do not combine with other macrocyclic-lactone medicines. The longer twice-daily 10-14-day schedule applies only to feline leukaemia, immunodeficiency or coronavirus-enteritis viral-load reduction under veterinary care.
 · treatment: twice daily for 5-7 days, then once daily for 5 days; prevention: once daily for 3-4 days		 treatment: twice daily for 5-7 days, then once daily for 5 days; prevention: once daily for 3-4 days Georgia Yes, veterinary
In force until 26 Jul 2029
Veterinary (National Food Agency)
In the register: არბიმექტინი
№ 000709
Verified on: 21 Oct 2026
Details: pack, label wording, sources, registration

Arbimectin 3/40 mg tablets, Tablet

N6 for large dogs
vetman assessment
vetman’s 10-point assessment brings together a product’s regulatory credibility, clinical efficacy, safety and practicality. Cost-effectiveness is assessed only when reliable data are available. It is informational and does not replace a veterinarian’s clinical judgment for an individual patient.
Dog
3.5/10
Poor / unconvincing
vetman assessment

Arbimectin

3/40 mg tablets, N6 for large dogs
Assessed clinical scopeDog · Full labelled canine oral scope: prevention of viral disease and adjunct treatment of distemper, adenoviral infection, parvoviral and coronavirus enteritis, bordetellosis and parainfluenza · oral
Care settingVeterinary-selected adjunctive home treatment after diagnosis and standard-of-care planning, with close response and neurologic monitoring
vetman score 3.5/10 Poor / unconvincing
Evidence confidence: Low Georgia: Yes, veterinary · № 000709 · Verified on 21 Oct 2026

The exact registered tablet is identifiable, but its broad antiviral and infection claims are not supported by reliable clinical benefit: the exact trial found no statistically significant advantage. Do not substitute it for vaccination, diagnosis or standard supportive/etiologic care; if used as an adjunct, apply strict ivermectin and ABCB1 risk screening and monitoring.

Regulatory and scientific credibility4.0/10

The exact presentation is currently registered in Georgia and current instructions verify identity, composition and labelled use. However, no EMA/FDA-style public assessment or transparent full dossier was found; umifenovir is reserved for human use and prohibited in animals under EU Regulation 2022/1255; and the only exact-tablet clinical trial is sponsor-linked, reports no statistically significant benefit and still concludes efficacy. The evidence gate therefore applies.

Clinical efficacy2.5/10

The exact 2024 tablet study included 120 dogs across four size strata and four infections; improvement was generally only 0-2 days earlier and no statistically significant group difference was found. The paper nevertheless called the product effective, while current review evidence considers veterinary antiviral activity of ivermectin exploratory and clinically unproven. The broad prevention and treatment scope is therefore not credibly demonstrated.

Safety and tolerability3.5/10

The exact short field study reported no adverse reactions, but it did not establish a safety margin for repeated twice-daily courses or uncommon events. Ivermectin neurotoxicity is exposure- and ABCB1-dependent, especially in susceptible herding breeds; the label excludes puppies under 10 weeks, animals under 1 kg, pregnancy and lactation, and no specific antidote exists.

Clinical practicality4.5/10

Oral administration with food and quarter-tablet increments are feasible at home, but treatment is twice daily for 5-7 days and then daily for 5 days, or twice daily for 10-14 days for selected feline claims. Exact weight-band selection and repeated tablet splitting are required, and one N6 pack is commonly insufficient for a full course.

Full-course cost-effectiveness-

Price was not assessed and is excluded from the overall score.

Important safety and use flags

  • Do not use with hypersensitivity to either component, in animals under 10 weeks or under 1 kg, or during pregnancy or lactation.
  • Do not combine with another macrocyclic lactone. Review all antiparasitics and interacting P-glycoprotein substrates or inhibitors before treatment.
  • Use cautiously in hypertension or epilepsy. Monitor appetite, gastrointestinal signs, behaviour and neurologic status throughout the repeated course.
  • Depression, hypersalivation, anorexia, diarrhoea, tremor or other neurologic signs may indicate excess exposure. Stop treatment and provide prompt supportive care; no specific antidote is available.
  • The exact tablet trial found no statistically significant clinical advantage, and independent exact-product replication was not found. Do not interpret the broad label as proof of antiviral efficacy.
  • This is labelled only as adjunctive treatment. It must not delay pathogen-directed therapy, fluid and nutritional support, isolation, analgesia or other standard care appropriate to the diagnosis.
  • The prevention claim is not a substitute for evidence-based vaccination, infection control or exposure management.
  • Use the exact strength and weight-band table and quarter tablets accurately. Full treatment commonly requires multiple packs; verify that the complete course can be supplied before starting.
  • Umifenovir is reserved for human use and may not be used in animals in the European Union under Regulation (EU) 2022/1255. Georgian registration does not remove this major international regulatory and antimicrobial-stewardship conflict.
  • Collies, Shelties, Old English Sheepdogs and related herding breeds may have ABCB1-associated ivermectin sensitivity. Use only after veterinary risk assessment, preferably with known ABCB1 status.
Assessment sources
  1. Arbimectin PVR-3-21.20/035972026
  2. Agrobioprom Arbimectin2026
  3. Georgia NFA register 20262026
  4. Arbimectin trial2024
  5. Ivermectin review2026
  6. Ivermectin toxicity2026
  7. ABCB1 review2023
  8. EU Regulation 20222022
Assessed: 22 Oct 2026The overall score uses 25/25/25/15/10 weights. An unassessed price is excluded and the remaining weights are proportionally renormalised.
Composition / strength
Ivermectin3 mg/tablet Umifenovir hydrochloride40 mg/tablet
Formulation Type
Tablet
Administration route
By mouth
Manufacturer
Agrobioprom JSC · Russia
Manufacturer (register)
Agrobioprom LTD, Russia
Manufacturer and country as in the veterinary medicines register (National Food Agency), row 1198, 19 Oct 2026.
Source: NFA veterinary medicines register ↗
Registration
Georgia Yes, veterinary
In force until 26 Jul 2029
Veterinary (National Food Agency)
In the register: არბიმექტინი
№ 000709
Verified on: 21 Oct 2026
Controlled in Georgia
Unknown
DoseSpeciesWeightRouteFrequencySource
1/2 tablet
Give individually with a small amount of food or directly, whole, crushed or dissolved in water. Keep fresh drinking water available. Do not use in pregnancy or lactation, under 10 weeks, below 1 kg, or with ingredient hypersensitivity. Collies, Shelties and Bobtails require veterinary supervision. Use cautiously with hypertension or epilepsy. Do not combine with other macrocyclic-lactone medicines. The longer twice-daily 10-14-day schedule applies only to feline leukaemia, immunodeficiency or coronavirus-enteritis viral-load reduction under veterinary care.
 Dog 1–10 kg By mouth treatment: twice daily for 5-7 days, then once daily for 5 days; prevention: once daily for 3-4 days
Arbimectin PVR-3-21.20/03597
Official product label (SPC)
Approved by a medicines regulator as part of the product's authorisation. It applies to that product as authorised there.
Arbimectin tablets - complete registration-linked instruction
Russian veterinary register mirror and current manufacturer catalogue, 2026
1 tablet
Give individually with a small amount of food or directly, whole, crushed or dissolved in water. Keep fresh drinking water available. Do not use in pregnancy or lactation, under 10 weeks, below 1 kg, or with ingredient hypersensitivity. Collies, Shelties and Bobtails require veterinary supervision. Use cautiously with hypertension or epilepsy. Do not combine with other macrocyclic-lactone medicines. The longer twice-daily 10-14-day schedule applies only to feline leukaemia, immunodeficiency or coronavirus-enteritis viral-load reduction under veterinary care.
 Dog 10–20 kg By mouth treatment: twice daily for 5-7 days, then once daily for 5 days; prevention: once daily for 3-4 days
Arbimectin PVR-3-21.20/03597
Official product label (SPC)
Approved by a medicines regulator as part of the product's authorisation. It applies to that product as authorised there.
Arbimectin tablets - complete registration-linked instruction
Russian veterinary register mirror and current manufacturer catalogue, 2026
1 1/2 tablets
Give individually with a small amount of food or directly, whole, crushed or dissolved in water. Keep fresh drinking water available. Do not use in pregnancy or lactation, under 10 weeks, below 1 kg, or with ingredient hypersensitivity. Collies, Shelties and Bobtails require veterinary supervision. Use cautiously with hypertension or epilepsy. Do not combine with other macrocyclic-lactone medicines. The longer twice-daily 10-14-day schedule applies only to feline leukaemia, immunodeficiency or coronavirus-enteritis viral-load reduction under veterinary care.
 Dog 20–30 kg By mouth treatment: twice daily for 5-7 days, then once daily for 5 days; prevention: once daily for 3-4 days
Arbimectin PVR-3-21.20/03597
Official product label (SPC)
Approved by a medicines regulator as part of the product's authorisation. It applies to that product as authorised there.
Arbimectin tablets - complete registration-linked instruction
Russian veterinary register mirror and current manufacturer catalogue, 2026
2 tablets
Give individually with a small amount of food or directly, whole, crushed or dissolved in water. Keep fresh drinking water available. Do not use in pregnancy or lactation, under 10 weeks, below 1 kg, or with ingredient hypersensitivity. Collies, Shelties and Bobtails require veterinary supervision. Use cautiously with hypertension or epilepsy. Do not combine with other macrocyclic-lactone medicines. The longer twice-daily 10-14-day schedule applies only to feline leukaemia, immunodeficiency or coronavirus-enteritis viral-load reduction under veterinary care.
 Dog 30–40 kg By mouth treatment: twice daily for 5-7 days, then once daily for 5 days; prevention: once daily for 3-4 days
Arbimectin PVR-3-21.20/03597
Official product label (SPC)
Approved by a medicines regulator as part of the product's authorisation. It applies to that product as authorised there.
Arbimectin tablets - complete registration-linked instruction
Russian veterinary register mirror and current manufacturer catalogue, 2026
1 tablet per 20 kg
Give individually with a small amount of food or directly, whole, crushed or dissolved in water. Keep fresh drinking water available. Do not use in pregnancy or lactation, under 10 weeks, below 1 kg, or with ingredient hypersensitivity. Collies, Shelties and Bobtails require veterinary supervision. Use cautiously with hypertension or epilepsy. Do not combine with other macrocyclic-lactone medicines. The longer twice-daily 10-14-day schedule applies only to feline leukaemia, immunodeficiency or coronavirus-enteritis viral-load reduction under veterinary care.
 Dog over 40 kg By mouth treatment: twice daily for 5-7 days, then once daily for 5 days; prevention: once daily for 3-4 days
Arbimectin PVR-3-21.20/03597
Official product label (SPC)
Approved by a medicines regulator as part of the product's authorisation. It applies to that product as authorised there.
Arbimectin tablets - complete registration-linked instruction
Russian veterinary register mirror and current manufacturer catalogue, 2026
9/120 mg tablets, Tablet · Dog 15–30 kg Dog 15–30 kg 1/2 tablet
Give individually with a small amount of food or directly, whole, crushed or dissolved in water. Keep fresh drinking water available. Do not use in pregnancy or lactation, under 10 weeks, below 1 kg, or with ingredient hypersensitivity. Collies, Shelties and Bobtails require veterinary supervision. Use cautiously with hypertension or epilepsy. Do not combine with other macrocyclic-lactone medicines. The longer twice-daily 10-14-day schedule applies only to feline leukaemia, immunodeficiency or coronavirus-enteritis viral-load reduction under veterinary care.
 · treatment: twice daily for 5-7 days, then once daily for 5 days; prevention: once daily for 3-4 days		 treatment: twice daily for 5-7 days, then once daily for 5 days; prevention: once daily for 3-4 days Georgia Yes, veterinary
In force until 26 Jul 2029
Veterinary (National Food Agency)
In the register: არბიმექტინი
№ 000660
Verified on: 21 Oct 2026
9/120 mg tablets, Tablet · Dog 30–45 kg Dog 30–45 kg 3/4 tablet
Give individually with a small amount of food or directly, whole, crushed or dissolved in water. Keep fresh drinking water available. Do not use in pregnancy or lactation, under 10 weeks, below 1 kg, or with ingredient hypersensitivity. Collies, Shelties and Bobtails require veterinary supervision. Use cautiously with hypertension or epilepsy. Do not combine with other macrocyclic-lactone medicines. The longer twice-daily 10-14-day schedule applies only to feline leukaemia, immunodeficiency or coronavirus-enteritis viral-load reduction under veterinary care.
 · treatment: twice daily for 5-7 days, then once daily for 5 days; prevention: once daily for 3-4 days		 treatment: twice daily for 5-7 days, then once daily for 5 days; prevention: once daily for 3-4 days Georgia Yes, veterinary
In force until 26 Jul 2029
Veterinary (National Food Agency)
In the register: არბიმექტინი
№ 000660
Verified on: 21 Oct 2026
9/120 mg tablets, Tablet · Dog 45–60 kg Dog 45–60 kg 1 tablet
Give individually with a small amount of food or directly, whole, crushed or dissolved in water. Keep fresh drinking water available. Do not use in pregnancy or lactation, under 10 weeks, below 1 kg, or with ingredient hypersensitivity. Collies, Shelties and Bobtails require veterinary supervision. Use cautiously with hypertension or epilepsy. Do not combine with other macrocyclic-lactone medicines. The longer twice-daily 10-14-day schedule applies only to feline leukaemia, immunodeficiency or coronavirus-enteritis viral-load reduction under veterinary care.
 · treatment: twice daily for 5-7 days, then once daily for 5 days; prevention: once daily for 3-4 days		 treatment: twice daily for 5-7 days, then once daily for 5 days; prevention: once daily for 3-4 days Georgia Yes, veterinary
In force until 26 Jul 2029
Veterinary (National Food Agency)
In the register: არბიმექტინი
№ 000660
Verified on: 21 Oct 2026
9/120 mg tablets, Tablet · Dog over 60 kg Dog over 60 kg 1 tablet per 60 kg
Give individually with a small amount of food or directly, whole, crushed or dissolved in water. Keep fresh drinking water available. Do not use in pregnancy or lactation, under 10 weeks, below 1 kg, or with ingredient hypersensitivity. Collies, Shelties and Bobtails require veterinary supervision. Use cautiously with hypertension or epilepsy. Do not combine with other macrocyclic-lactone medicines. The longer twice-daily 10-14-day schedule applies only to feline leukaemia, immunodeficiency or coronavirus-enteritis viral-load reduction under veterinary care.
 · treatment: twice daily for 5-7 days, then once daily for 5 days; prevention: once daily for 3-4 days		 treatment: twice daily for 5-7 days, then once daily for 5 days; prevention: once daily for 3-4 days Georgia Yes, veterinary
In force until 26 Jul 2029
Veterinary (National Food Agency)
In the register: არბიმექტინი
№ 000660
Verified on: 21 Oct 2026
Details: pack, label wording, sources, registration

Arbimectin 9/120 mg tablets, Tablet

N10 for XL dogs
vetman assessment
vetman’s 10-point assessment brings together a product’s regulatory credibility, clinical efficacy, safety and practicality. Cost-effectiveness is assessed only when reliable data are available. It is informational and does not replace a veterinarian’s clinical judgment for an individual patient.
Dog
3.5/10
Poor / unconvincing
vetman assessment

Arbimectin

9/120 mg tablets, N10 for XL dogs
Assessed clinical scopeDog · Full labelled canine oral scope: prevention of viral disease and adjunct treatment of distemper, adenoviral infection, parvoviral and coronavirus enteritis, bordetellosis and parainfluenza · oral
Care settingVeterinary-selected adjunctive home treatment after diagnosis and standard-of-care planning, with close response and neurologic monitoring
vetman score 3.5/10 Poor / unconvincing
Evidence confidence: Low Georgia: Yes, veterinary · № 000660 · Verified on 21 Oct 2026

The exact registered tablet is identifiable, but its broad antiviral and infection claims are not supported by reliable clinical benefit: the exact trial found no statistically significant advantage. Do not substitute it for vaccination, diagnosis or standard supportive/etiologic care; if used as an adjunct, apply strict ivermectin and ABCB1 risk screening and monitoring.

Regulatory and scientific credibility4.0/10

The exact presentation is currently registered in Georgia and current instructions verify identity, composition and labelled use. However, no EMA/FDA-style public assessment or transparent full dossier was found; umifenovir is reserved for human use and prohibited in animals under EU Regulation 2022/1255; and the only exact-tablet clinical trial is sponsor-linked, reports no statistically significant benefit and still concludes efficacy. The evidence gate therefore applies.

Clinical efficacy2.5/10

The exact 2024 tablet study included 120 dogs across four size strata and four infections; improvement was generally only 0-2 days earlier and no statistically significant group difference was found. The paper nevertheless called the product effective, while current review evidence considers veterinary antiviral activity of ivermectin exploratory and clinically unproven. The broad prevention and treatment scope is therefore not credibly demonstrated.

Safety and tolerability3.5/10

The exact short field study reported no adverse reactions, but it did not establish a safety margin for repeated twice-daily courses or uncommon events. Ivermectin neurotoxicity is exposure- and ABCB1-dependent, especially in susceptible herding breeds; the label excludes puppies under 10 weeks, animals under 1 kg, pregnancy and lactation, and no specific antidote exists.

Clinical practicality4.5/10

Oral administration with food and quarter-tablet increments are feasible at home, but treatment is twice daily for 5-7 days and then daily for 5 days, or twice daily for 10-14 days for selected feline claims. Exact weight-band selection and repeated tablet splitting are required, and one N6 pack is commonly insufficient for a full course.

Full-course cost-effectiveness-

Price was not assessed and is excluded from the overall score.

Important safety and use flags

  • Do not use with hypersensitivity to either component, in animals under 10 weeks or under 1 kg, or during pregnancy or lactation.
  • Do not combine with another macrocyclic lactone. Review all antiparasitics and interacting P-glycoprotein substrates or inhibitors before treatment.
  • Use cautiously in hypertension or epilepsy. Monitor appetite, gastrointestinal signs, behaviour and neurologic status throughout the repeated course.
  • Depression, hypersalivation, anorexia, diarrhoea, tremor or other neurologic signs may indicate excess exposure. Stop treatment and provide prompt supportive care; no specific antidote is available.
  • The exact tablet trial found no statistically significant clinical advantage, and independent exact-product replication was not found. Do not interpret the broad label as proof of antiviral efficacy.
  • This is labelled only as adjunctive treatment. It must not delay pathogen-directed therapy, fluid and nutritional support, isolation, analgesia or other standard care appropriate to the diagnosis.
  • The prevention claim is not a substitute for evidence-based vaccination, infection control or exposure management.
  • Use the exact strength and weight-band table and quarter tablets accurately. Full treatment commonly requires multiple packs; verify that the complete course can be supplied before starting.
  • Umifenovir is reserved for human use and may not be used in animals in the European Union under Regulation (EU) 2022/1255. Georgian registration does not remove this major international regulatory and antimicrobial-stewardship conflict.
  • Collies, Shelties, Old English Sheepdogs and related herding breeds may have ABCB1-associated ivermectin sensitivity. Use only after veterinary risk assessment, preferably with known ABCB1 status.
Assessment sources
  1. Arbimectin PVR-3-21.20/035972026
  2. Agrobioprom Arbimectin2026
  3. Georgia NFA register 20262026
  4. Arbimectin trial2024
  5. Ivermectin review2026
  6. Ivermectin toxicity2026
  7. ABCB1 review2023
  8. EU Regulation 20222022
Assessed: 22 Oct 2026The overall score uses 25/25/25/15/10 weights. An unassessed price is excluded and the remaining weights are proportionally renormalised.
Composition / strength
Ivermectin9 mg/tablet Umifenovir hydrochloride120 mg/tablet
Formulation Type
Tablet
Administration route
By mouth
Manufacturer
Agrobioprom JSC · Russia
Manufacturer (register)
Agrobioprom LTD, Russia
Manufacturer and country as in the veterinary medicines register (National Food Agency), row 1155, 19 Oct 2026.
Source: NFA veterinary medicines register ↗
Registration
Georgia Yes, veterinary
In force until 26 Jul 2029
Veterinary (National Food Agency)
In the register: არბიმექტინი
№ 000660
Verified on: 21 Oct 2026
Controlled in Georgia
Unknown
DoseSpeciesWeightRouteFrequencySource
1/2 tablet
Give individually with a small amount of food or directly, whole, crushed or dissolved in water. Keep fresh drinking water available. Do not use in pregnancy or lactation, under 10 weeks, below 1 kg, or with ingredient hypersensitivity. Collies, Shelties and Bobtails require veterinary supervision. Use cautiously with hypertension or epilepsy. Do not combine with other macrocyclic-lactone medicines. The longer twice-daily 10-14-day schedule applies only to feline leukaemia, immunodeficiency or coronavirus-enteritis viral-load reduction under veterinary care.
 Dog 15–30 kg By mouth treatment: twice daily for 5-7 days, then once daily for 5 days; prevention: once daily for 3-4 days
Arbimectin PVR-3-21.20/03597
Official product label (SPC)
Approved by a medicines regulator as part of the product's authorisation. It applies to that product as authorised there.
Arbimectin tablets - complete registration-linked instruction
Russian veterinary register mirror and current manufacturer catalogue, 2026
3/4 tablet
Give individually with a small amount of food or directly, whole, crushed or dissolved in water. Keep fresh drinking water available. Do not use in pregnancy or lactation, under 10 weeks, below 1 kg, or with ingredient hypersensitivity. Collies, Shelties and Bobtails require veterinary supervision. Use cautiously with hypertension or epilepsy. Do not combine with other macrocyclic-lactone medicines. The longer twice-daily 10-14-day schedule applies only to feline leukaemia, immunodeficiency or coronavirus-enteritis viral-load reduction under veterinary care.
 Dog 30–45 kg By mouth treatment: twice daily for 5-7 days, then once daily for 5 days; prevention: once daily for 3-4 days
Arbimectin PVR-3-21.20/03597
Official product label (SPC)
Approved by a medicines regulator as part of the product's authorisation. It applies to that product as authorised there.
Arbimectin tablets - complete registration-linked instruction
Russian veterinary register mirror and current manufacturer catalogue, 2026
1 tablet
Give individually with a small amount of food or directly, whole, crushed or dissolved in water. Keep fresh drinking water available. Do not use in pregnancy or lactation, under 10 weeks, below 1 kg, or with ingredient hypersensitivity. Collies, Shelties and Bobtails require veterinary supervision. Use cautiously with hypertension or epilepsy. Do not combine with other macrocyclic-lactone medicines. The longer twice-daily 10-14-day schedule applies only to feline leukaemia, immunodeficiency or coronavirus-enteritis viral-load reduction under veterinary care.
 Dog 45–60 kg By mouth treatment: twice daily for 5-7 days, then once daily for 5 days; prevention: once daily for 3-4 days
Arbimectin PVR-3-21.20/03597
Official product label (SPC)
Approved by a medicines regulator as part of the product's authorisation. It applies to that product as authorised there.
Arbimectin tablets - complete registration-linked instruction
Russian veterinary register mirror and current manufacturer catalogue, 2026
1 tablet per 60 kg
Give individually with a small amount of food or directly, whole, crushed or dissolved in water. Keep fresh drinking water available. Do not use in pregnancy or lactation, under 10 weeks, below 1 kg, or with ingredient hypersensitivity. Collies, Shelties and Bobtails require veterinary supervision. Use cautiously with hypertension or epilepsy. Do not combine with other macrocyclic-lactone medicines. The longer twice-daily 10-14-day schedule applies only to feline leukaemia, immunodeficiency or coronavirus-enteritis viral-load reduction under veterinary care.
 Dog over 60 kg By mouth treatment: twice daily for 5-7 days, then once daily for 5 days; prevention: once daily for 3-4 days
Arbimectin PVR-3-21.20/03597
Official product label (SPC)
Approved by a medicines regulator as part of the product's authorisation. It applies to that product as authorised there.
Arbimectin tablets - complete registration-linked instruction
Russian veterinary register mirror and current manufacturer catalogue, 2026

Ivermectin: No dose supported by a publicly verifiable source yet

Umifenovir hydrochloride: No dose supported by a publicly verifiable source yet

Known Contraindications

  • Known Breed Sensitivities Ivermectin
    Collie, Collie (unspecified), Collie - Scottish Rough, Collie - Scottish Smooth, Sheepdog - Old English, Sheepdog - Shetland (Sheltie), Shetland Sheepdog
    Ivermectin: collies and related herding breeds with the MDR1 (ABCB1) deletion are sensitive to it. The heartworm-prevention dose (6 µg/kg) is tolerated; higher doses (the label: more than 16 times that) can cause dilated pupils, unsteadiness, tremors, coma and death. Give antiparasitic doses only to a dog tested MDR1 normal.

Professional reference for veterinary professionals. Not advertising and not a substitute for the product label/SPC.

For veterinary professionals only. It does not replace clinical judgement or the product label; check the dose in the official label (SPC). vetman is not liable for harm caused by using this information.

Trademarks belong to their owners; vetman is not affiliated with the manufacturers and receives no payment from them.

The database is protected under Chapter VII of the Law of Georgia on Copyright and Related Rights; automated or bulk copying is prohibited.

This reference is still growing. Missing a product? Let us know. · Report an error or request an addition · Updated: 21 Oct 2026

All of this shows in vetman as you prescribe

The dose for the patient's weight, registration in Georgia and controlled status, right on the prescription.

Register Demo ↗